Prolidase Could Act as a Diagnosis and Treatment Mediator in Lung Fibrosis

Urotensin-II in systemic sclerosis: a new peptide in pathogenesis

(2011) Yavuz Pehlivan et al.   CLINICAL RHEUMATOLOGY

Association Between Thr21Met and Ser89Asn Polymorphisms of the Urotensin II Gene and Systemic Sclerosis

(2011) Y. PEHLIVAN et al.   JOURNAL OF RHEUMATOLOGY

Serum prolidase enzyme activity and its relation to histopathological findings in patients with non-alcoholic steatohepatitis

(2010) Mehmet Horoz et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Urotensin-II Contributes to Pulmonary Vasoconstriction in a Perinatal Model of Persistent Pulmonary Hypertension of the Newborn Secondary to Meconium Aspiration Syndrome

(2010) Catherine M Simpson et al.   PEDIATRIC RESEARCH

Pharmacokinetics and Pharmacodynamics of the Urotensin-II Receptor Antagonist Palosuran in Healthy Male Subjects

(2009) Patricia N. Sidharta et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF-β1-mediated renal fibrosis and dysfunction

(2008) Lin Tian et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Diagnostic Value of Serum Prolidase Enzyme Activity to Predict the Liver Histological Lesions in Non-alcoholic Fatty Liver Disease: A Surrogate Marker to Distinguish Steatohepatitis from Simple Steatosis

(2008) Huseyin Kayadibi et al.   DIGESTIVE DISEASES AND SCIENCES